-
1
General Considerations on Clinical Trials of Hemophilia Medicines
Published 2020-03-01Subjects: Get full text
Article -
2
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
Published 2025-05-01Subjects: Get full text
Article -
3
Effects of different storage temperatures and durations on the activity of coagulation factor Ⅷ and Ⅸ in whole blood
Published 2025-06-01Subjects: Get full text
Article -
4
APTAMERS ARE NEW PHARMACOLOGICAL SUBSTANCES FOR THE DEVELOPMENT OF ANTICOAGULANTS
Published 2017-05-01Subjects: Get full text
Article -
5
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
Published 2018-09-01Subjects: Get full text
Article -
6
Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options
Published 2024-10-01Subjects: “…factor IX…”
Get full text
Article -
7
RENAL ALLOGENEIC TRANSPLANTATION IN PATIENT WITH HAEMOPHILIA B
Published 2014-12-01Subjects: Get full text
Article -
8
Hemophilic Arthropathy—Pathophysiology and Advances in Treatment
Published 2025-04-01Subjects: Get full text
Article -
9
Identification of Novel F9 Gene Variants in 143 Vietnamese Patients with Hemophilia B
Published 2025-04-01Subjects: “…factor ix…”
Get full text
Article -
10
Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light
Published 2012-01-01Subjects: Get full text
Article -
11
Extravascular factor IX after gene therapy in hemophilia B, does it matter?
Published 2025-02-01Subjects: Get full text
Article